CAS: 1791420-09-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Dilpacimab REF: TM-T77157CAS: 1791420-09-1 | - - - | To inquire | Mon 02 Dec 24 |
 | Dilpacimab REF: 3D-CLA1529CAS: 1791420-09-1 | - - - | To inquire | Thu 12 Dec 24 |
Dilpacimab
CAS:1791420-09-1
Dilpacimab (ABT165) is a dual-target antibody for DLL4 and VEGF, used in cancer research.
Color and Shape:
Liquid
Ref: TM-T77157
| 5mg | To inquire |
Estimated delivery in United States, on Monday 2 Dec 2024
Dilpacimab
CAS:1791420-09-1
A humanized dual-variable domain antibody targets both delta-like ligand 4 (DLL4) and VEGF pathways
Ref: 3D-CLA1529
| Undefined size | To inquire |
Estimated delivery in United States, on Thursday 12 Dec 2024
